Latest Advances in Lung Cancer Research

Lung cancer rates are increasing among Asian American women, according to a new study published in the journal Cancer.

Weill Cornell Medicine scientists create a mouse model to study lung cancer’s transformation into deadly SCLC.

David P. Carbone, MD, PhD, sought to transform lung cancer care and did it—but didn’t anticipate the personal journey it would put him on.

Rising lung cancer in young, non-smoking women puzzles doctors; research on potential pregnancy link and new causes is crucial for prevention and early detection.

Recent studies confirm genomic testing for NSCLC enhances treatment choices and survival, advocating for its standardization in clinical practice.

A novel nanoparticle vaccine halts lung cancer spread in mice by training the immune system to attack tumor cells, showing promise for post-surgery cancer prevention.

UCLA researchers received a $6 million grant to refine a liquid biopsy blood test for early, accurate lung cancer detection and treatment guidance.

Johnson & Johnson’s Rybrevant shows comparable efficacy to AstraZeneca’s Tagrisso in advanced NSCLC, suggesting potential as an initial treatment option.

Experimental gene therapy drug HPN328 is being tested with Tecentriq in a trial to enhance immune response against small cell lung cancer.

Adding atezolizumab and tiragolumab to chemotherapy may improve survival in extensive stage small cell lung cancer, with further research needed.

Fred Hutchinson Cancer Center received a $30 million NCI grant to enhance cancer research and support vital services for the next five years.

At the 2023 World Conference, lung cancer advocacy triumphed with a 25% funding boost for the Lung Cancer Research Program, thanks to strategic lobbying and a unified advocacy platform.